Sumalpong, Tata Eldie E.
HRN: 25-69-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/19/2024
09/21/2024
IV
600mg
Every 6 Hours
S/P AKA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes